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1. Introduction 
Advanced technologies have made a significant impact on the development of drug 
delivery systems over the last few years and is remodeling the future of therapeutic 
care of patients. In particular, microparticles made from biocompatible polymers for 
pharmaceutical applications, where bioactive agents are continuously released from 
the particle as a function of time has been extensively studied. The 
electrohydrodynamic atomization technique, commonly known as electrospraying, 
has several key advantages compared to other techniques for making particles in the 
microscale such as improvement of dissolution rate of poorly water-soluble drugs, 
batch-scalability, reproducibility, effective encapsulation and simple setup 
configurations in microparticle production. Drug release characteristics are enhanced 
by using biodegradable polymer carriers, which sustain the release of encapsulated 
drugs. Moreover, multi-pharmacy can be achieved by loading different drugs into 
multi layered particles via electrospraying, and the controlled release of these 
ingredients have been made possible. Modern day electrospraying can involve very 
advanced technological features such as simultaneous multi-flow 
electrohydrodynamics to deliver polypharmacy. In this editorial, we combine key 
reports on electrosprayed microparticles and their corresponding therapeutic 
applications. However, advancing this technology and particle characteristics to 
reliable dosage mass production and manufacturing for patient healthcare still 
requires significant research and development.
Several techniques have been developed for the encapsulation of therapeutic agents 
such as emulsion solvent evaporation/extraction, spray drying, electrospraying, 
coacervation and microfluidics. Microparticles produced by these techniques have 
been extensively investigated for pharmaceutical applications, especially drug 
delivery.  It is crucial to develop microparticles with better controlled features 
including size, shape, surface properties and component materials, which enables 
enhanced delivery of therapeutics  [1].
The most impressive and largely studied method is electrohydrodynamic 
atomization, also known as electrospraying. Electrospinning and 
electrohydrodynamic printing belong to the same family of process, and in general 
electrospraying occurs with solutions have lower viscosities. The phenomenon of 
electrohydrodynamic atomization was described in 1600 when William Gilbert 
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reported that a jet of liquid could be emitted from a droplet via an electrostatically 
charged chamber [2] It is used for producing microparticles for pharmaceutical 
applications due to several key advantages compared to other techniques such as 
the capability of spraying a wide range of materials, flexibility and versatility with 
various simple setup configurations for different applications, generation of smaller 
particles with better size distribution and much less agglomeration, and improved 
dissolution of poorly water-soluble drugs. Therefore, electrospraying is one of the 
most fascinating tools to be employed in the pharmaceutical field.
The basic setup for electrospraying consists of several components: a syringe pump, 
a metal nozzle connected to a high voltage power source, a grounded substrate as 
collector and a monitor.  In order to control better the process of particle forming and 
facilitate the generation of smaller particles with smoother surface morphology, the 
electrospraying setup should be isolated in a covered chamber [3]. Basically, a 
stream of conductive liquid is pumped into a nozzle to which the high voltage (kV 
range) is applied during electrospraying to form microparticles. The principle of 
electrospraying is based upon the theory of charged droplets and this static charge 
causes an electrostatic force in the droplets [4]. Only fragments of solution are jetted 
at a low voltage, creating various modes such as dripping, rapid dripping and 
unstable cone-jet mode. A sustained and a continuous jet can be obtained from the 
balance of several forces including surface tension, gravity and electric strengths on 
the liquid surface; these are stable cone-jet, multi-jet and irregular unstable jet 
modes (Figure 1). The electrospray process is also influenced by the liquid 
properties including surface tension, viscosity, electrical conductivity and density as 
illustrated in Figure 2.  
2. Pharmaceutical applications
Water solubility ratio of the drug is a crucial factor for drug effectiveness, especially 
for the oral route. The electrospraying process improves the dissolution of poorly 
water-soluble drugs. In literature data, the Edirisinghe Laboratory 
(www.edirisinghelab.com) demonstrated that microparticles containing poorly water-
soluble drugs, biopharmaceutical classification system class II drug, such as 
progesterone [3], celecoxib [5], cisplatin [6,7] can be successfully produced by 
electrospraying. More importantly, different release profiles can be obtained due to 
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the specialties and ratios of different polymers or polymer composites for controlling 
the release profile of drugs. For instance, progesterone-loaded poly(lactic-co-
glycolic) acid (PLGA) particles were prepared in different copolymer ratios by 
electrospraying and the results indicated that decrease in poly(lactic) 
acid:poly(glycolic) acid (PLA:PGA) ratio from 75:25 to 50:50 accelerated the release 
of progesterone [3].
Electrospraying has also been successfully used for targeted therapeutic delivery 
systems by encapsulation of drugs into a suitable carrier. Through this method, not 
only the characteristics of drug release is predictable and can be controlled in a 
sustained, pulsed or prolonged manner, but also, the drug can be released at the 
diseased site to provide high and exclusive accumulation at the specific location. 
Moreover, this system can protect the drug from degradation and loss of bioactivity 
compared to other conventional dosage forms. Researchers have designed a smart 
multifunctional microcapsule of paclitaxel with titanium dioxide (TiO2) shell using the 
co-axial electrospray [8]. Tetrabutyl titanium and Poly(vinylpyrrolidone) (PVPk-30) 
were blended into a mixed solution of ethanol, DMF and acetic acid used for outer 
liquid. Paclitaxel, modified Fe3O4, and graphene quantum dots were dispersed in 
olive oil and used as the inner solution. The initial burst release of paclitaxel was 
suppressed by the TiO2 shell. The Fe3O4 inside the core shell functioned 
successfully for magnetic targeting. Moreover, ultrasound was employed to stimulate 
the release of paclitaxel, and the release behavior could be controlled by the length 
of repeatable ultrasound [8].
Recently, successful processing and entrapment of therapeutic agents into a 
biodegradable polymer matrix for sustained release applications using 
electrospraying has been demonstrated in several studies. PLGA, poly(caprolactone) 
(PCL), PLA, and their derivatives are the most frequently used biodegradable 
polymers approved by The Food and Drug Administration. As shown in Table 1, 
there are many examples of drugs that were entrapped into these polymers by 
electrospraying. Researchers successfully encapsulated cisplatin into PLGA matrix 
by electrospraying and the release profile of cisplatin was controlled by altering 
polymer concentration [6]. In another study, two different configurations of 
electrospraying setups were used to produce cisplatin-loaded PLGA polymeric 
particles and to control the distribution of cisplatin within the particles. It was shown 
that core-shell structured particles had more sustained release compared to the 
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uniform particles [7].
In addition to encapsulation of a single drug, electrospraying has also been used for 
delivering multiple drugs (polypharmacy) in that two or more therapeutic agents can 
be encapsulated into a polymer matrix or multi-shell structured particles. A co-axial 
capillary device incorporating three needles sharing the same vertical axis was used 
to produce triple-layered capsules composed of PLGA and poly(DL-lactic acid) 
(PDLLA) containing paclitaxel and doxorubicin. By simple changing the flow rate and 
polymer concentration at each layer, the particle size and shell thickness can be 
controlled. The study showed that drug burst release was reduced [9]. In fact, such 
devices were invented in the last 10 years and has now led to the creation of an 
electrospraying device, which incorporates four co-axial needles, which can create 
for new levels of polypharmacy [10].
3. Expert opinion
Micro/nanomaterials have great potential in the medicinal and pharmaceutical field 
due to mimicking the size range of biological molecules and entities. Polymer-based 
microparticles play a key role as vehicles in the controlled delivery of different forms 
and types of active substances, such as antidiabetic, anticancer, antihypertensive 
drugs, immunomodulatory agents, hormones, vitamins, nucleic acids, proteins, and 
antibodies. Polymers such as PLGA, PCL, PLA etc. are approved by World Health 
Organization and Food and Drug Administration as substances that can be used in 
medicine and pharmacy. These biodegradable polymers have various specialties 
such as desirable processing characteristics, biocompatibility, and biodegradation at 
rates that can be arranged for the intended application. The release of medicines 
inside particles can be sustained over a long period, or cyclic over a long period, or 
burst release in a short time, or it can be released by environmental or other external 
effects. The crucial aim of controlling the drug release is improving the effectiveness 
of therapies, preventing both insufficient and overdosing intake. Moreover, 
controlled-delivery systems can maintain the drug levels within the desired range, 
decrease the frequency of dosage, ensuring better stability of the incorporated 
substances against degradation (e.g enzymatic), reduce toxicity, and increase 
patient compliance.
Page 5 of 14





























































For Peer Review Only
Information Classification: General
The biggest challenge facing the adaptation of electrosprayed microparticles in drug 
delivery at a commercial level are mass production and reliability of dosage. The 
former requires the creation of innovative engineering and this is in progress [10] 
where therapeutic product comprising of layered electrosprayed microparticles may 
bring relief to patients suffering from chronic conditions, e.g. urinary tract infections 
(UTI), which cost the NHS in the UK a vast amount of expenditure. Current oral and 
other treatment strategies used in these instances may not be so effective and in the 
longer term can lead to the microbes developing resistance to the antibiotics. The 
reliability of the therapeutics mass produced will also depend on modern but simple 
and economical engineering, i.e. will each drug microcapsule offer the same dosage 
and release characteristics, this will depend on controlling the size distribution of the 
particles precisely. 
Overall, electrohydrodynamic routes are in competition with other new technologies 
being developed, such as gyration [11] and microfluidic methods [12] to manufacture 
products. Therefore, rapid investment is necessary to take a perfectly viable 
laboratory-scale technique to a genuine industrial manufacturing route.
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Figure 1. Schematic illustration of various modes of electrospraying 
a) Dripping mode b) Rapid dripping mode c) Unstable cone-jet mode
d) Stable cone-jet mode e) Multi-jet mode f) Irregular instable mode
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Figure 2. The effects of liquid properties on the electrospraying process. 
Liquid properties
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Table 1. Drug loading and release characteristics of electrosprayed particles loaded with various bioactive agents
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